The IVDR transition is reshaping how IVD manufacturers approach compliance, evidence, and certification. This session will guide you through the most critical elements of the journey, from transition timelines and legacy provisions, to EUDAMED and UDI requirements, and what they mean in practice.

We will also dive into Class C classification and conformity assessment pathways, highlight the most common clinical evidence gaps identified by Notified Bodies, and share practical insights on how to work more effectively with Notified Bodies, including smarter communication and selection strategies to support successful approvals.


Join us to gain clarity, reduce compliance risks, and strengthen your IVDR strategy. Register now to secure your spot.